# A Study Comparing the Local Tolerability of Two Subcutaneous Heparins in Healthy Volunteers.

> **NCT03841396** · PHASE4 · COMPLETED · sponsor: **Aspen Global Incorporated** · enrollment: 15 (actual)

## Conditions studied

- Injection Site Reaction

## Interventions

- **DRUG:** Sodium chloride

## Key facts

- **NCT ID:** NCT03841396
- **Lead sponsor:** Aspen Global Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-02
- **Primary completion:** 2016-07-15
- **Final completion:** 2016-07-15
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2019-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03841396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03841396, "A Study Comparing the Local Tolerability of Two Subcutaneous Heparins in Healthy Volunteers.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03841396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*